Evidence map›Paper›PMID 33260575›Full record

ArticleMaterials (Basel, Switzerland)2020

Photocatalytic Performance Evaluation of Titanium Dioxide Nanotube-Reinforced Cement Paste.

Junxing Liu, Hyeonseok Jee, Myungkwan Lim, Joo Hyung Kim, Seung Jun Kwon, Kwang Myong Lee, Erfan Zal Nezhad, Sungchul Bae

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Photoactive Cements: A Review.Materials (Basel, Switzerland) · 2022
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Junxing LiuDepartment of Architectural Engineering, Hanyang University, 222, Wangsimni-ro, Sungdong-gu, Seoul 04763, Korea.ORCID 0000-0002-6947-6627
Hyeonseok JeeDepartment of Architectural Engineering, Hanyang University, 222, Wangsimni-ro, Sungdong-gu, Seoul 04763, Korea.ORCID 0000-0003-4784-1053
Myungkwan LimDepartment of Architecture Engineering, Songwon University, Gwangju 61756, Korea.ORCID 0000-0002-0493-4439
Joo Hyung KimKorea Conformity Lab, Construction Technology Research Center, Construction Division, Seoul 08503, Korea.
Seung Jun KwonDepartment of Civil and Environmental Engineering, Hannam University, Daejeon 306-791, Korea.
Kwang Myong LeeDepartment of Civil, Architectural, and Environmental System Engineering, Sungkyunkwan University, Gyeonggi-Do 16419, Korea.
Erfan Zal NezhadDepartment of Chemical and Biomedical Engineering, University of Texas at San Antonio (UTSA), San Antonio, TX 78249, USA.
Sungchul BaeDepartment of Architectural Engineering, Hanyang University, 222, Wangsimni-ro, Sungdong-gu, Seoul 04763, Korea.ORCID 0000-0002-8511-6939

Funding

Korea Institute of Energy Technology Evaluation and Planning 20181110200070
6 · The paper itself

Abstract

Considering the increase in research regarding environmental pollution reduction, the utilization of cementitious material, a commonly used construction material, in photocatalysts has become a desirable research field for the widespread application of photocatalytic degradation technology. Nano-reinforcement technology for cementitious materials has been extensively researched and developed. In this work, as a new and promising reinforcing agent for cementitious materials, the photocatalytic performance of titanium dioxide nanotube (TNT) was investigated. The degradation of methylene blue was used to evaluate the photocatalytic performance of the TNT-reinforced cement paste. In addition, cement paste containing micro-TiO

Indexed as

anatase TiO2cement pastehydration productsphotocatalysistitanium dioxide nanotube

Identifiers

PMID33260575
PMCPMC7729800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.